Cullinan Therapeutics Inc (CGEM)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -32.61M | -62.76M | -37.61M | -44.8M | -45.93M | -42.99M | -50.03M | -48.86M |
| Pre Tax Income | -28.95M | -58.14M | -32.21M | -39.18M | -39.69M | -37.34M | -42.03M | -40.56M |
| Net Income | -26.78M | -57.96M | -32.21M | -39.18M | -23.8M | -37.15M | -42.03M | -40.56M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -32.55M | -62.65M | -37.54M | -44.62M | -46.04M | -43.03M | -50.1M | -48.94M |
| EBITDA | -32.55M | -62.68M | -37.52M | -44.72M | -45.41M | -42.91M | -49.95M | -48.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 18.94M | 0 | 0 |
| Operating Income | -22.27M | -60.34M | -67.95M | -132.14M | -191.09M |
| Pre Tax Income | -21.65M | -59.46M | -67.49M | 151.32M | -169.22M |
| Net Income | -20.66M | -51.8M | -65.57M | 111.21M | -153.16M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.736 | -4.354 | -1.167 | 1.929 | -2.768 |
| EBIT | -22.27M | -60.35M | -67.96M | 144.71M | -190.85M |
| EBITDA | -22.17M | -60.24M | -67.85M | -132.04M | -190.34M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
